Researchers at Vanderbilt University have developed two new chemical compounds. These compounds are designed to investigate the TAOK protein family, which has been linked to Alzheimer's disease. The first compound, VU6083859, is a selective inhibitor of TAOK-1. The second compound, VU6080195, activates all three proteins in the TAOK family.
Alzheimer's disease is the leading cause of dementia. It affects over seven million people in the United States. Current treatments primarily address symptoms. There is no cure for the disease.
Understanding the underlying biology of Alzheimer's disease is a significant challenge. Scientists use tool compounds to study proteins. These compounds can increase or decrease protein activity. This research can lead to new treatment developments.
TAOK-1 is a protein associated with Alzheimer's disease. Its function has been difficult to study due to a lack of specific research tools. The new selective inhibitor, VU6083859, provides a way to investigate TAOK-1's role. The pan-TAOK activator, VU6080195, offers an unexpected tool to study the effects of increased TAOK protein activity.
These compounds allow scientists to explore the TAOK protein family more deeply. This research could uncover hidden disease mechanisms. It may also lead to new treatment strategies for Alzheimer's and other neurological conditions. The findings were published in *ACS Chemical Neuroscience*.
Related stories
Aging Protein Linked to Neurodegenerative Disease in Worms and Cells
Scientists have discovered a protein, EPS8, that accumulates with age and may trigger neurodegenerative diseases like ALS and Huntington's by promoting toxic protein aggregation.
Weekly Interval Walking Reduces Body Fat and Improves Fitness
A study found that 75 minutes of brisk interval walking once a week can reduce body fat and improve fitness as effectively as three weekly sessions.
Daily Avocado Consumption May Reduce Heart Disease Risk
A study found that eating one avocado daily may reduce heart disease risk in adults with obesity by lowering harmful LDL particle levels in the blood.